[Recommendations for diagnosis and treatment of ankylosing spondylitis]

Zhonghua Nei Ke Za Zhi. 2022 Aug 1;61(8):893-900. doi: 10.3760/cma.j.cn112138-20211226-00913.
[Article in Chinese]

Abstract

Ankylosing spondylitis (AS) is a chronic inflammatory disease mainly affecting the sacroiliac joints, spine and peripheral joints. In China, standardized diagnosis and treatment of AS is still to be popularized. Based on the evidence and guidelines from China and other countries, Chinese Rheumatology Association developed standardization of diagnosis and treatment of AS. The purposes are: (1) to standardize the diagnosis and evaluation of AS; (2) to promote rational use of non-steroidal anti-inflammatory drugs, biological as well as traditional disease modifying anti-rheumatic drugs, so as to improve the patient's quality of life.

强直性脊柱炎(AS)是一种主要侵犯骶髂关节、脊柱和外周关节的慢性炎症性疾病。在我国,AS的规范化诊断和治疗仍有待普及。中华医学会风湿病学分会结合我国国情,在借鉴国内外诊治经验和指南的基础上,制定了本规范,旨在规范AS的诊断和病情评估,合理使用非甾体抗炎药、生物和传统合成改善病情抗风湿药,提高患者的生活质量。.

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antirheumatic Agents* / therapeutic use
  • Humans
  • Quality of Life
  • Sacroiliac Joint
  • Spondylitis, Ankylosing* / drug therapy
  • Spondylitis, Ankylosing* / therapy

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antirheumatic Agents